| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
21,650 |
19,560 |
$2.80M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17,689 |
17,342 |
$757K |
| 87631 |
|
15,342 |
15,070 |
$753K |
| 87481 |
|
6,544 |
6,303 |
$423K |
| 87581 |
|
13,709 |
13,475 |
$350K |
| 87486 |
|
13,650 |
13,418 |
$350K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13,336 |
13,067 |
$309K |
| 87640 |
|
7,346 |
7,166 |
$154K |
| 87653 |
|
7,377 |
7,196 |
$152K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,147 |
4,985 |
$96K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,104 |
4,946 |
$95K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,620 |
4,465 |
$93K |
| 87563 |
|
1,648 |
1,594 |
$68K |
| 87529 |
|
1,867 |
1,827 |
$65K |
| 87511 |
|
2,545 |
2,459 |
$55K |
| 87507 |
|
235 |
232 |
$43K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
232 |
232 |
$30K |
| 87541 |
|
1,237 |
1,226 |
$24K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
113 |
112 |
$3K |
| 87641 |
|
107 |
105 |
$3K |
| 87593 |
|
96 |
93 |
$2K |